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bstract
Human papillomavirus type 16 (HPV16) infects anogenital epithelia and is the etiological agent of cervical cancer. We showed previously
hat HPV16 infection regulates the key splicing/alternative splicing factor SF2/ASF and that virus late transcripts are extensively alternatively
pliced. hnRNP A1 is the antagonistic counterpart of SF2/ASF in alternative splicing. We show here that hnRNP A1 is also up-regulated during
ifferentiation of virus-infected epithelial cells in monolayer and organotypic raft culture. Taken together with our previous data on SF2/ASF, this
omprises the first report of HPV-mediated regulation of expression of two functionally related cellular proteins during epithelial differentiation.
urther, using electrophoretic mobility shift assays and UV crosslinking we demonstrate that hnRNP A1 binds the HPV16 late regulatory element
LRE) in differentiated HPV16 infected cells. The LRE has been shown to be important in temporally controlling virus late gene expression
uring epithelial differentiation. We suggest that increased levels of these cellular RNA processing factors facilitate appropriate alternative splicing
ecessary for production of virus late transcripts in differentiated epithelial cells.
2007 Elsevier B.V.
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. Introduction
Human papillomaviruses (HPVs) are small circular double-
tranded DNA viruses that infect both cutaneous and mucosal
pithelia (Howley, 1996). HPV infection commonly causes
enign papillomas or warts. A significant subset of HPVs infects
Abbreviations: HPV16, human papillomavirus type 16; ESS, exonic splic-
ng suppressor; LRE, late regulatory element; 3′ UTR, 3′ untranslated region;
MSA, electrophoretic mobility shift assay; SR proteins, serine/arginine-rich
roteins; GST, glutathioneS-transferase; RBD, RNA-binding domain; SF2/ASF,
plicing factor 2/alternative splicing factor; hnRNP A1, heterogeneous ribonu-
leoprotein particle A1; U1snRNP, U1 small nuclear ribonucleoprotein particle;
HK, normal human keratinocytes; CAT, chloramphenicol acetyltransferase.
∗ Corresponding author at: Institute of Comparative Medicine, Jarrett Build-
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Open access under CC BY license.he anogenital tract. These can be divided into “low risk” and
high risk types”. The latter types can cause lesions that, on
ome rare occasions, develop to malignancy. Often, integration
f high-risk HPV DNA into host genomes is an essential first step
n the tumourigenesis pathway but this integration event abro-
ates completion of the normal virus life cycle. HPV16 is one of
he most abundant high-risk types associated with approximately
0% of cervical cancer cases worldwide (zur Hausen, 1996).
During a normal infection, transcription of the 7.9 kb
PV16 genome yields polycistronic RNAs, which are processed
y alternative splicing to produce mature messenger RNAs
Milligan et al., 2007). The virus genome can be sub-divided into
hree parts, an early region containing six early genes (E1–E7),
late region with two late genes (L1 and L2), and a long con-
rol region (LCR). The HPV life cycle is completely dependent
pon epithelial differentiation. The six early proteins, which are
ainly involved in episomal maintenance of the virus genome,
ranscriptional regulation, and cell transformation, are produced
hroughout the virus life cycle (zur Hausen, 1996). In contrast,
xpression of the virus capsid proteins, L1 and L2 is restricted to
190 T. Cheunim et al. / Virus Research 131 (2008) 189–198
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2ig. 1. RNA sequence of the HPV16 LRE at the junction of the L1 open readin
he four weak 5′ splice sites (Cumming et al., 2003) are underlined and the 3′ G
RE probes used in experiments described in Fig. 5 are indicated beneath the s
erminally differentiated epithelial cells. Restriction of produc-
ion of the highly immunogenic capsid proteins to these cells
ay allow the virus to complete its life cycle undetected by
he host immune response (Stoler et al., 1989; Stubenrauch and
aimins, 1999).
Cis-acting regulatory elements have been identified in the
oding regions and the late 3′ untranslated regions (UTRs) of
everal papillomaviruses (Graham, 2006). It is proposed that
hese elements employ different RNA-based mechanisms to reg-
late virus late gene expression. Two HPV16 coding sequence
lements have been suggested to regulate splice site selection.
he first, in the E4 open reading frame acts as a splicing enhancer
o facilitate early mRNA processing and inhibit late gene expres-
ion (Rush et al., 2005). The 5′ end of the L1 open reading frame
arbours a number of regulatory sequences stretching over 514
ucleotides (Collier et al., 2002) that are proposed to inhibit
uclear RNA processing. There is good evidence that the core
f this element binds heterogeneous nuclear ribonucleoprotein
article (hnRNP) A1 and it acts as a splicing silencer, at least in
eLa cells, to suppress the use of the splice acceptor site located
t the 5′ end of the L1 open reading frame (Zhao et al., 2004).
nhibitory elements also exist in the L2 coding region of HPV16.
he L2 elements are poorly defined but bind hnRNP K and
oly(rC)-binding proteins 1 and 2 and may regulate translation
Collier et al., 1998).
The best characterised 3′ UTR regulatory element is the
ovine papillomavirus type 1 (BPV1) inhibitory element, which
s located in the BPV1 long control region. It is 53 nucleotides
n length and contains a good consensus 5′ splice site. This 5′
plice donor site base-pairs with the 5′ end of U1 snRNA, allow-
ng U1 snRNP to assemble on the element (Furth and Baker,
991; Furth et al., 1994). A direct consequence of this binding
s that U1 70 K, one subunit of U1 snRNP, interacts with poly(A)
olymerase to inhibit polyadenylation (Gunderson et al., 1998).
t is thought that this mechanism is employed to inhibit virus late
ene expression in undifferentiated, BPV1 infected cells, but it
emains unclear how such suppression is released to allow late
ene expression in terminally differentiated cells.
A similar element is present in the HPV16 late 3′ UTR. This
9-nt late regulatory element (LRE) overlaps the 3′ end of L1
ene and extends into the late 3′ UTR (Kennedy et al., 1990).
he element can be divided into two parts, a 5′ LRE portion,hat contains four weak 5′ splice sites, and a 3′ LRE portion
hat is GU-rich (Fig. 1). Site-directed mutation analysis revealed
hat the entire sequence is required for the repressive function
f the element on gene expression in undifferentiated epithe-
2
ae and the long control region (LCR). The L1 UAA stop codon is in bold type.
h region is in italic type. A putative hnRNP A1 binding site is boxed. Truncated
ce.
ial cells (Cumming et al., 2003). A U1 snRNP-like complex
lso binds this element (Cumming et al., 2003). In addition,
t can also bind the auxiliary splicing factor U2AF (Dietrich-
oetz et al., 1997), the key SR protein SF2/ASF (McPhillips et
l., 2004), the polyadenylation factor CstF64, and the elav-like
huttling protein HuR (Koffa et al., 2000) suggesting that the
lement regulates virus late gene expression by more than one
ost-transcriptional pathway.
If these elements regulate viral RNA processing during the
irus life cycle then the proteins they bind may be regulated dur-
ng epithelial differentiation. So far only SF2/ASF levels have
een shown to respond to virus infection and epithelial differ-
ntiation (McPhillips et al., 2004). Increased levels of SF2/ASF
ay facilitate the extensive splicing and alternative splicing of
irus late transcripts that is required in virus-infected, differ-
ntiated epithelial cells (Milligan et al., 2007). The counterpart
f SF2/ASF in splicing regulation is hnRNP A1 (Pinol-Roma,
997). While SF2/ASF binds exonic sequence enhancers to
romote splicing of nearby introns, hnRNP A1 binds exonic
equence silencers to inhibit such splicing (Sanford et al., 2005).
here is evidence for regulation of alternative splicing pat-
erns by these two proteins in a concentration-dependent manner
Eperon et al., 2000). Studies in mice suggested that hnRNP A1
nd SF2/ASF expression varies among tissues and different pro-
ortions of the two proteins were also observed (Hanamura et
l., 1998; Kamma et al., 1995). In addition to regulating splic-
ng, hnRNP A1 has been reported to be involved in mRNA
xport (Izaurralde et al., 1997; Mili et al., 2001), mRNA stability
Hamilton et al., 1997) and translation (Bonnal et al., 2005).
In this study, we demonstrate a significant specific increase
n expression of nuclear hnRNP A1 during differentiation of
PV16 genome-containing epithelial cells in both monolayer
nd organotypic raft culture. The timing and level of increase is
imilar to that of SF2/ASF, the counterpart of hnRNP A1 in splic-
ng regulation. Further, we demonstrate that hnRNP A1 binds
he HPV16 LRE in the nucleus of differentiated W12 cells and
ST-hnRNP A1 can bind the element directly in vitro. HPV16-
nduced changes in expression of both hnRNP A1 and SF2/ASF
ay facilitate alternative splicing of virus late transcripts.
. Experimental.1. Cell culture
The 20863 (W12E) cell line is a subclone of the W12 line,
n HPV16 positive cell line derived from a low-grade cervical
Resea
l
c
c
a
a
c
l
c
g
d
a
f
a
w
(
f
2
0
N
(
w
2
t
(
m
4
d
b
s
D
d
(
S
B
A
w
(
m
P
r
t
2
P
s
a
s
t
m
fi
c
E
t
N
K
E
e
E
g
2
A
f
b
f
1
1
a
f
5
t
B
2
t
(
(
8
N
T
P
P
N
N
N
NT. Cheunim et al. / Virus
esion (Stanley et al., 1989), which contains 50–100 episomal
opies of HPV16 genomes (Jeon et al., 1995). The HaCaT
ell line is a spontaneously immortalised aneuploid human ker-
tinocyte line, which is capable of differentiation (Boukamp et
l., 1988; Schoop et al., 1999). For monolayer culture, W12E
ells were co-cultured with mitomycin C-treated J2 3T3 fibrob-
ast feeder cells at a ratio of 1:5, seeding W12E cells at 2 × 105
ells/100 mm dish (McPhillips et al., 2004). The W12E line was
rown for up to 5 days for undifferentiated cells, and 10 days for
ifferentiated cells, respectively. The HaCaT cells were seeded
t similar density but grew more rapidly and so were grown
or 3 days for undifferentiated cells, and 6 days for differenti-
ted cells. All cell lines were cultured in DMEM supplemented
ith 10% foetal calf serum, 2 mM glutamine, cholera toxin
8.4 ng/ml), hydrocortisone (0.4g/ml), and epidermal growth
actor (10 ng/ml).
.2. Nuclear and cytoplasmic extraction
For W12 cells, feeder cells were removed by treatment with
.1% trypsin–0.5 mM EDTA prior to utilising for extraction.
uclear and cytoplasmic extracts were prepared as described
Dignam et al., 1983). In some cases, HeLa nuclear extracts
ere purchased from 4C Biotech, Seneffe, Belgium.
.3. Western blotting
Proteins were separated on 12% SDS-PAGE before elec-
roblotting onto polyvinylidene fluoride (PVDF) membranes
Amersham). The membranes were blocked in 5% (w/v) dried
ilk powder in phosphate-buffered saline (PBS) overnight at
◦C. Primary antibodies were diluted in PBS with 5% (w/v)
ried milk powder, 0.05% (v/v) Tween-20 (PBS-T) and incu-
ated with the membranes for 1 h at room temperature with
haking. The anti-hnRNP A1 antibody, 4B10 (gift from Gideon
reyfuss, University of Pennsylvania, USA), was used at a
ilution of 1/500, monoclonal antibodies against SF2/ASF
Mab 96; Zymed), involucrin (SY5; Sigma), keratin 10 (K8.60;
igma), filaggrin (PRB-417P; CRP Inc.) and GAPDH (6CS;
iodesign International) were used at a dilution of 1/1000.
fter washing with PBS-T, the membranes were incubated
ith an anti-mouse secondary antibody–horseradish peroxidase
Sigma) at a dilution of 1/1000 in PBS-T with 5% (w/v) dried
ilk powder for 1 h at room temperature. Following washing in
BS-T, antibody–protein complexes were visualised using ECL
eagents (Amersham) according to the manufacturer’s instruc-
ions.
D
s
e
1
able 1
rimer sequences and annealing positions in the HPV16 genome for generation of te
rimer name Promoter Genomic location (nts) Sequences
RE probe forward T3 7128–7144 5′ CAGAGA
RE probe reverse None 7186–7207 5′ CTGAGC
RE 15–55 forward T3 7142–7163 5′ CAGAGA
RE 50–79 forward T3 7177–7192 5′ CAGAGArch 131 (2008) 189–198 191
.4. Electrophoretic mobility shift assay (EMSA)
Primer sequences used to generate riboprobe templates by
CR amplification of pCATPE445 (Cumming et al., 2003) are
hown in Table 1. PCR products were purified on 6% poly-
crylamide gels. Using in vitro transcription, riboprobes were
ynthesised with the Stratagene RNA transcription kit with addi-
ion of 25Ci [-32P]UTP (800 mCi/mmol; NEN) following the
anufacturer’s protocol. The full-length riboprobes were puri-
ed from a 5% denaturing polyacrylamide gel. EMSAs were
arried out as described (Black et al., 1998). For competition
MSAs, specific competitor RNA was in vitro transcribed with
he addition of unlabeled UTP substituting for [-32P] UTP.
on-specific competitor RNA was transcribed from pBluescript
S(+) (Stratagene) polylinker linearised with EcoRI. Supershift
MSA experiments were carried out by preincubation of nuclear
xtracts with the anti-hnRNP A1 antibody for 30 min on ice. The
MSA reactions were electrophoresed on a 5% non-denaturing
el.
.5. GST-hnRNP A1 protein puriﬁcation
GST-tagged hnRNP A1 expression plasmid (pGEX-hnRNP
1; gift from Ron Hay, University of Dundee, UK) was trans-
ormed into BL-21 cells with induction of protein expression
y adding 250l IPTG (100 mg/ml) to the cell culture. Trans-
ormed cells were lysed in 1 ml lysozyme (10 mg/ml) on ice for
5 min before incubating with 100l Triton X-100 for another
5 min. The supernatant was collected by spinning at 9500 rpm
nd mixed with 1 ml of 50% glutathione sepharose (Amersham)
or 1 h before washing with PBS. The protein was eluted in
mM reduced glutathione in 50 mM Tris pH 8.0 three times and
he concentration of the purified hnRNP A1 was determined by
radford assay.
.6. Immunohistochemistry and immunoﬂuorescence of raft
issues
Organotypic raft culture was carried out as described
Meyers et al., 1992). Briefly, to establish a collagen matrix
2.5–3.0 ml/raft), 6.25 × 105 J2 3T3 cells were mixed with
0% collagen type IV, 10% reconstitution buffer (2.2% (w/v)
aHCO3, 4.77% (w/v) HEPES in 0.062N NaOH), 10% 10×
MEM, and 0.024N NaOH. The collagen mixture was left to
olidify in a 6-well cell culture plate before seeding 1.0 × 106
pithelial cells suspended in E-medium (Meyers and Laimins,
994) onto the collagen matrix surface. After incubating
mplates for UV crosslinking and EMSA RNA probes
TGCAATTAACCCTCACTAAAGGGGCTAAACGCAAAAAACG 3′
TCACATACAAACATATACACAAC 3′
TGCAATTAACCCTCACTAAAGGGCGTAAGCTGTAAGTATG 3′
TGCAATTAACCCTCACTAAAGGGAGAATTCGTGTTGTTTGTTGTGT 3′
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vernight at 37 ◦C to allow cells to attach to the surface of the
ollagen gel, and before adding E-medium, the raft system was
ransferred to a wire grid to bring the system up to the liquid–air
nterface. The rafts were fed with fresh E-medium containing
8:0 (10M) on alternate days for 12 days.
Organotypic raft tissues were fixed in 10% neutral-buffered
ormalin overnight, paraffin-embedded, cut into 4m cross
ections, and placed on poly-l-lysine (Sigma) coated slides.
mmunohistochemistry was carried out using the ABC Elite kit
Vector Laboratories) according to the manufacturer’s instruc-
ion. Briefly, sections were dewaxed by incubating in xylene
nd rehydrated in a graded series of alcohol (100%, 100%, 95%,
5%, and 50% ethanol). Antigen retrieval was achieved by heat-
ng in citrate buffer (1.5 mM citric acid, 8.0 mM Tri-sodium
itrate) for 15 min before blocking the sections with normal
locking buffer for 30 min. Monoclonal antibody was added
or 1 h at room temperature. Diaminobenzidine tetrahydrochlo-
ide (DAB) (Vector Laboratories) was used as the chromagen
o visualise the sections. Monoclonal antibodies against involu-
rin (SY5; Sigma; 1/1000) and hnRNP A1 (4B10; 1/1000) were
sed. For immunofluorescence, after being dewaxed and rehy-
rated, the sections were blocked in PBS-20% calf serum for
h before incubating with primary antibody for 1 h at 4 ◦C. Fol-
owing washing with PBS, the sections were incubated with
ITC conjugated secondary antibody for 1 h and mounted in
ECTASHIELD mounting medium with DAPI (Vector Labo-
atories), and visualised using a Zeiss LSM510 laser scanning
onfocal microscope.
. Results
.1. hnRNP A1 expression is up-regulated during HPV16
nfected epithelial cell differentiation
We reported previously that the key splicing regulator
F2/ASF is up-regulated during differentiation of HPV16
nfected epithelial cells. The antagonistic counterpart of
F2/ASF in regulating alternative splicing is hnRNP A1 (Eperon
t al., 2000). HPV16 late transcripts are extensively alterna-
ively spliced (Milligan et al., 2007) so we examined the relative
evels of hnRNP A1 and SF2/ASF during epithelial differen-
iation using the W12 cell line. W12 cervical epithelial cells
re immortal, but not transformed, differentiate in monolayer
nd organotypic raft culture and harbour episomal copies of the
PV16 genome (Jeon et al., 1995). Upon differentiation W12
ells express markers of differentiated epithelial cells and begin
o express virus late proteins (McPhillips et al., 2004; Milligan
t al., 2007) making them a good model system for the infectious
ife cycle of HPV16 in cervical epithelial cells. In addition, we
arried out a similar analysis in HaCaT cells. The immortalised
aCaT human keratinocyte cell line contains no virus genomes
Boukamp et al., 1988; Schoop et al., 1999) but, similar to the
12 line, is able to differentiate in monolayer and organotypicaft culture (McPhillips et al., 2004). We used HaCaT cells rather
han normal human keratinocytes (NHKs) because in mono-
ayer culture, in our hands, HaCaT cells differentiate to a greater
xtent. In addition, we chose HaCaT cells over NHKs to allow
w
p
k
arch 131 (2008) 189–198
omparison of levels of proteins in two established cell lines
ather than in primary cells versus established cell lines. Any
uch comparison has pitfalls so in the quantification analyses
12 and HaCaT cells are dealt with separately. In Fig. 2 levels of
xpression of individual proteins in each line are expressed rela-
ive to levels of expression of the housekeeping protein GAPDH
n undifferentiated or differentiated cells. Differentiation of W12
nd HaCaT cells was demonstrated by expression of involucrin
nd keratin 10, both markers of differentiated suprabasal epithe-
ial cells, and filaggrin, a marker of granular layer cells (Fig. 2H).
or filaggrin, bands from 30 to 20 kDa were observed in the dif-
erentiated cells. This ladder of bands results from degradation of
he protein, an event observed in late stages of epithelial differ-
ntiation (Fuchs, 1990). Expression of filaggrin demonstrated
hat a good level of epithelial differentiation was achieved in
12 cells and HaCaT cells although levels of the protein were
ot as high in the latter. In addition, expression of the major
apsid protein, L1, in differentiated W12 cells confirmed that
irus late gene expression was achieved. Besides SF2/ASF and
nRNP A1, levels of expression of a range of RNA processing
actors that had previously been suggested to regulate HPV late
ene expression were examined by Western blotting (Dietrich-
oetz et al., 1997; Cumming et al., 2003; McPhillips et al.,
004). Expression of hnRNP A1 was up-regulated in differen-
iated W12E cells (Fig. 2B) while in differentiated HaCaT cells
down-regulation was observed compared to undifferentiated
ells. Quantification of results from five Western blot experi-
ents indicated that there was a four to eight-fold up-regulation
f hnRNP A1 during W12E differentiation (Fig. 2B) similar to
hat found for SF2/ASF (McPhillips et al., 2004). In contrast,
here was around a two-fold decrease in hnRNP A1 levels in
ifferentiated, compared to undifferentiated HaCaT cells. It is
lear that HaCaT cells do not differentiate to the same extent
s W12 cells. So final levels of hnRNP A1 in fully differ-
ntiated normal keratinocytes may be even smaller than that
bserved in HaCaT cells suggesting an even greater difference in
evels of the protein in differentiated virus-infected versus non-
irus-infected cells. We confirmed this decrease in hnRNP A1
xpression during differentiation of normal human keratinocytes
rown in organotypic raft culture (Fig. 3C). No significant up-
egulation of other RNA processing proteins, whether splicing
elated (Fig. 2, C–E) or not (Fig. 2Fand G), was observed (note
he changed Y-axis scale) demonstrating that levels of SF2/ASF
nd hnRNP A1 were specifically increased in differentiated
12 cells.
In case the changes in hnRNP A1 levels we observed were
pecific to differentiation in monolayer culture, we carried out
mmunofluorescence studies in W12E organotypic raft culture
issue. Involucrin expression commenced in the cell cytoplasm
f the suprabasal layers as expected, indicating that these cells
ere differentiated (Fig. 3A). Similarly, increased levels of
nRNP A1 were clearly observed in the suprabasal layers of
he raft tissue but the protein showed strong nuclear staining,
ith some cytoplasmic staining as expected (Fig. 3B). Com-
ared to W12E tissue, raft tissue derived from normal human
eratinocytes (Fig. 3C) showed staining with anti hnRNP A1
ntibody in immunohistochemistry mainly in the basal layer
T. Cheunim et al. / Virus Research 131 (2008) 189–198 193
Fig. 2. hnRNP A1 is up-regulated during differentiation of W12E cells. Cell lysates were prepared from undifferentiated (U) and differentiated (D) W12E and HaCaT
cells. 10g of each extract was fractionated on SDS-PAGE and Western blotted with antibodies against the proteins indicated beside the graphs associated with each
set of Western blots. (A) SF2/ASF (B) hnRNP A1 (C) U2AF65 (D) Sm protein (E) U1A (F) CstF-64 (G) HuR. Graphs show quantification of the Western blot data
by densitometry scanning and show the mean and standard deviation from the mean of three to five separate experiments. The scale on the Y-axis in (A) and (B) is
different to the scale for (C–G). (H) Western blots of undifferentiated and differentiated W12 and HaCaT cells probed with antibodies against involucrin, keratin 10
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wnd filaggrin to demonstrate extent of differentiation of the cells. W12 cell ext
roteins, associated with terminally differentiated, virus-infected epithelial cell
nd a decreased level of staining in the suprabasal layers. This
onfirms our Western blot data in monolayer cells. Immunohis-
ochemistry using antibodies against SF2/ASF (manuscript in
reparation), HuR (manuscript in revision), U1A and U2AF65
onfirmed the results of the remaining Western data (data not
hown).
.2. The HPV16 LRE interacts with hnRNP A1hnRNP A1 has been shown to bind an exonic sequence
ilencer in the 5′ portion of the L1 open reading frame (Zhao et
l., 2004). However, the HPV16 LRE that regulates late gene
i
b
a
awere probed with an anti-L1 antibody to demonstrate production of virus late
ts were reprobed with an antibody against GAPDH as a loading control.
xpression also contains a potential hnRNP A1 binding site
Fig. 1) (Burd and Dreyfuss, 1994), and if it bound hnRNP
1, this complex could be part of, or compete with, the LRE-
inding SF2/ASF-containing complex (McPhillips et al., 2004).
e determined whether the LRE interacts with hnRNP A1 using
MSA and UV crosslinking studies. Fig. 4A, tracks 2 and 4,
hows that complexes formed when radiolabelled LRE RNA
as incubated with HeLa and W12 nuclear extracts. The bind-ng pattern in W12E cells was compared to that in HeLa cells
ecause HeLa extracts are most frequently used in the liter-
ture to demonstrate binding of proteins to RNA (e.g. Burd
nd Dreyfuss, 1994). When the extracts were preincubated with
194 T. Cheunim et al. / Virus Research 131 (2008) 189–198
Fig. 3. Immunostaining of organotypic raft culture sections demonstrating epithelial differentiation stage-specific and HPV16-mediated regulation of hnRNP A1.
4m raft tissue sections stained with (A) anti-involucrin antibody or (B) anti-hnRNP A1 antibody. Nuclei are stained with DAPI. The basal and suprabasal layers
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tf the epithelia are indicated. The dotted red line indicates the junction of the r
brown colour) of a 4m section of normal human foreskin keratinocytes. Nucl
pithelium are indicated.
nti hnRNP A1 antibody (tracks 3 and 5) supershifted bands
ere observed (starred bands) indicating that hnRNP A1 is a
omponent of at least one of the complexes. In track 3 a band
starred) can be observed with lower mobility than the upper-
ost band in track 2 indicating that the antibody has reacted with
he RNA/protein complex and retarded its mobility. In track 5
obility of the upper band has been retarded (starred) but a
upershift has also been induced in the lower band (arrowhead)
ndicating that there may be two different hnRNP A1-containing
NA/protein complexes that can form upon the LRE in W12
xtracts. Next UV-crosslinking studies were used to confirm the
MSA data. Fig. 4C shows that at least seven proteins were UV-
rosslinked to the LRE from HeLa cell extracts (Fig. 4C, tracks
and 2) and from differentiated W12 cell extracts (tracks 5 and
). In contrast only one major band was detected with undiffer-
ntiated W12 cell extracts (tracks 3 and 4) although the same
mount of protein extract was used in each crosslinking reac-
ion. In HeLa and differentiated W12 cells more proteins were
ound in nuclear extract than in cytoplasmic extract. Fig. 4D
hows that when the gel was Western blotted and probed with
n anti-hnRNP A1 antibody, bands were detected in tracks 1 and
. Binding was most efficient in the presence of nuclear extract
here the protein is most abundant (Fig. 4B) as expected. This
ndicates that hnRNP A1 can bind the LRE in W12 cells in
differentiation stage-specific manner. Fig. 4B demonstrates
ifferentiation of the W12 cells and efficient fractionation of
he nuclear and cytoplasmic compartments and confirms up-
egulation of hnRNP A1 in differentiated W12 cells. GAPDH
t
e
e
csue and the collagen layer. (C) Immunohistochemistry staining for hnRNP A1
counterstained with eosin (blue colour). The basal and suprabasal layers of the
NA levels vary during epithelial differentiation with a decrease
uring differentiation (Steele et al., 2002). We have observed a
onsistent small decrease in levels of GAPDH protein (Fig. 2H)
pon differentiation and this may account for the reduction in
evels of the protein in the nuclear fraction observed in Figure 4B,
rack 4.
.3. hnRNP A1 directly interacts with the LRE
To discover whether hnRNP A1 could interact directly with
he LRE, GST-hnRNP A1 was expressed and purified from E.
oli and then incubated with [-32P]-labelled full-length LRE
robe in an EMSA experiment. Direct binding of hnRNP A1 to
he LRE began to be observed at 90 nM (Fig. 5A, track 3) with
n increase in binding at 180 nM (Fig. 5A, track 4). A corre-
ponding, very significant decrease in levels of free probe could
e seen in this track as expected. Molar amounts of probe and
rotein were calculated such that the probe was always in excess.
his allows observation of increasing complex formation with
ncreasing protein concentration. However, free probe is never
ntirely depleted. GST alone did not bind the LRE (Fig. 5A
rack 1). Free probe migrated as two bands because the LRE
equence has the potential to form significant secondary struc-
ure (Cumming et al., 2003). Fig. 5A (tracks 5–7) shows that
he short 3′ LRE probe that is U-rich but does not contain the
ntire putative hnRNP A1 binding site did not bind the protein
fficiently because little complex formation was observed. In
ontrast, a region of the LRE containing the four weak 5′ splice
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Fig. 4. hnRNP A1 binds the HPV16 LRE. (A) Electrophoretic mobility shift assay showing interaction of hnRNP A1 and LRE RNA in HeLa and W12 cells. Free
probe and the RNA/protein complexes formed are indicated. Asterisks and an arrowhead indicate RNA/protein complexes that have been supershifted due to binding
of the anti-hnRNP A1 antibody in tracks 3 and 5. Track 1, [-32P] rUTP-labelled LRE RNA probe alone (the LRE RNA is a stem loop structure (Cumming et al.,
2003); the upper band is due to secondary structure formation); track 2, LRE RNA probe incubated with HeLa nuclear extract; track 3, as in track 2 but nuclear extract
preincubated with anti-hnRNP A1 antibody; track 4, LRE RNA probe incubated with W12E nuclear extract; track 5, as in track 4 but nuclear extract preincubated with
anti-hnRNP A1 antibody. (B) Western blot of nuclear (tracks 2 and 4) and cytoplasmic (tracks 1 and 3) extracts from undifferentiated (tracks 1 and 2) and differentiated
(tracks 3 and 4) W12E cells showing fractionation of U2AF65 and hnRNP A1 mainly with the nuclear fraction and involucrin mainly with the cytoplasmic fraction
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fis expected. The increase in levels of involucrin in tracks 3 and 4 confirms that t
f UV crosslinking of [-32P] rUTP-labelled LRE RNA probe with nuclear (NE
D) W12E cells. (D) Western blot of the SDS-PAGE in (C) probed with anti-hn
ites and the putative hnRNP A1 binding site bound the protein
ecause some complex formation could be seen. However, com-
lex formation was weak indicating that this probe did not bind
s well as the entire LRE sequence (Fig. 5A, tracks 6–10). This
ndicates that the entire LRE sequence is required for efficient
inding of hnRNP A1.
To demonstrate that hnRNP A1 binds specifically to the LRE,
ompetition EMSA experiments were performed. GST-hnRNP
1 was incubated with [-32P]-UTP-labelled LRE in the pres-
nce of non-specific or specific competitors (Fig. 5B). Inhibition
f complex formation occurred when cold LRE probe, a specific
ompetitor, was added to the reaction mixture at one-fold molar
xcess (Fig. 5B, tracks 1–5). When the cold competitor RNA
s in significant molar excess it can compete with the labelled
NA probe for binding hnRNP A1. In contrast, the non-specific
ompetitor, pBS polylinker RNA, could not interrupt complex
ormation when incubated with the probe from 1- to 16-fold
olar excess. This is because the non-specific competitor RNA
oes not have any binding sites for hnRNP A1. The data clearly
how that hnRNP A1 binds specifically to LRE-RNA.
i
(
o
S12 cells have differentiated. (C) Autoradiogram of an SDS-PAGE fractionation
cytoplasmic (CE) fractions of HeLa and undifferentiated (U) and differentiated
A1 antibody.
. Discussion
Using monolayer and organotypic raft culture systems, we
bserved up-regulation of hnRNP A1 during differentiation
f W12E cells, which contain episomal copies of the HPV16
enome and provide a good model for the life cycle of HPV16
n cervical epithelial cells. It is known that factors involved in
ene regulation are often up-regulated during tumour progres-
ion. This is not the reason for our observations here. First, the
12E line that we have used is capable of producing HPV16
apsid proteins (Fig. 2H) and thus of completing the virus life
ycle. Life cycle completion and tumourigenesis are thought
o be mutually exclusive events for HPVs. Second, when raft
ultures of a subclone of the W12 cell line, W12G, where the
irus genome is integrated into the host genome (one of the
rst steps in HPV-associated tumour progression) were exam-ned a diffuse uniform distribution of the protein was observed
data not shown). The pattern of up-regulation of expression
f hnRNP A1 is similar to what we observed previously for
F2/ASF (McPhillips et al., 2004). This regulation is specific for
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Fig. 5. Nuclear hnRNP A1 binds the LRE directly. (A) Electrophoretic mobility
shift analysis of binding of GST (500 nM) and GST-hnRNP A1 (45, 90, 180 nM)
to [-32P] rUTP-labelled LRE or truncated LRE RNA probes. The probes used
are shown in Fig. 1 and indicated below the autoradiograph. Arrows indicate
free probe. A bracket indicates RNA/protein complexes. (B) Competition elec-
trophoretic mobility shift experiment using a non-specific competitor, unlabelled
in vitro-transcribed pBluescript polylinker RNA (70 nts) (pBS) (lanes 1–5) or
a specific competitor, unlabelled in vitro transcribed LRE RNA (79 nts) (lanes
6–10). P; [-32P] rUTP-labelled LRE probe alone, N; probe plus nuclear extract.
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accurate production of virus late mRNAs as both these proteinsoth competitors were added to reactions at 1, 2, 4, 8 and 16-fold molar excess.
rrows indicate free probe. A bracket indicates protein/RNA complexes.
hese splicing factors because Western blot and immunostaining
f raft culture section with antibodies against a range of other
NA processing factors showed no such regulation (Fig. 2 and
ata not shown). The decrease in hnRNP A1 (and other RNA
rocessing proteins) levels in differentiated HaCaT cells and
HKs is expected. Differentiated epithelial cells begin to shut
ff nuclear functions and in the final stages of differentiation,
n the uppermost epithelial layers, the nuclei disintegrate. The
ifference in hnRNP A1 protein expression patterns between
on-virus-infected cells (HaCaT and NHK) and virus-infected
ells (W12E) implies that the presence of HPV16 genomes in
he infectious state (episomal genomes, capable of completing
he virus life cycle) in W12E cells caused these changes in lev-
ls of hnRNP A1. hnRNP A1 and SF2/ASF cooperate to define
xons and introns and to regulate alternative splicing by binding
o exonic splicing enhancers or exonic splicing silencer, respec-
a
irch 131 (2008) 189–198
ively (Caceres et al., 1994). This is the first report of regulation
f two functionally related cellular proteins by HPV infection in
n epithelial differentiation-specific manner. SF2/ASF expres-
ion is regulated by HPV16 E2 (McPhillips et al., 2004; Mole and
raham, manuscript in preparation). However, preliminary data
ndicates that E2 may not regulate expression of hnRNP A1 (data
ot shown) and we are currently investigating the mechanisms
pregulating this protein during differentiation of virus-infected
pithelia.
It has been proposed that changes in the relative levels of
F2/ASF and hnRNP A1 may be important in regulating splice
ite usage (Hanamura et al., 1998; Kamma et al., 1995). It is
lear that these proteins respond in a similar manner to virus
nfection during epithelial differentiation and this is suggestive
f a functional link. Early in the virus life cycle there may be
ittle need to splice the polycistronic transcripts produced from
he virus genome (Wildridge and Graham, unpublished data).
he major splice events that do occur are in the E6/E7 region
f the genome where splicing from nt 226 to 409 is important
Zheng et al., 2004). These 5′ and 3′ splice sites conform to good
onsensus sequence and may not require high levels of SF2/ASF
nd hnRNP A1 to regulate their use. mRNAs produced late in the
ife cycle utilise a good consensus 5′ splice site at nt 880 in the E1
pen reading frame but this is spliced to one of two possible 3′
plice sites; nt 3357 in the E2 open reading frame and nt 5637 in
he L2 open reading frame, both of which deviate somewhat from
he consensus sequence (Milligan et al., 2007), and may require a
ombination of SF2/ASF and hnRNP A1 binding to cognate sites
n the E4 (Rush et al., 2005) and L1 exons (Zhao et al., 2004) to
id their utilisation. Increasing levels of hnRNP A1 and SF2/ASF
n cells would aid this alternative splicing. These proteins are
ey regulators of alternative splicing of the tat gene of HIV-1
hrough competition for binding to a dual binding site in exon
(Zhu et al., 2001). In silico analysis of the L1 gene revealed
number of other potential hnRNP A1 binding site (data not
hown) as well as several SF2/ASF binding sites but none of
hese overlap. Although both proteins bind the LRE, SF2/ASF
oes not bind directly (McPhillips et al., 2004) meaning that they
re unlikely to compete for binding. hnRNP A1 appears to bind
ooperatively to exons in a 3′ to 5′ direction and such binding
an be blocked by SF2/ASF (Zhu et al., 2001; Damgaard et al.,
002; Marchand et al., 2002). Perhaps hnRNP A1 is recruited to
he LRE and aids further loading onto the L1 exon in competition
ith SR proteins. Finally, the distance between the LRE and the
1 coding region hnRNP A1 binding sites does not preclude
heir cooperation: although the cooperative mechanism has not
een worked out as yet, it is clear that hnRNP A1 binding sites
eed not be adjacent in exons and can indeed be some distance
part (Blanchette and Chabot, 1999). In addition, one of the
ey late events in the virus life cycle is amplification of virus
enomes from 50–100 copies to over 1000 copies, which may
ll be transcriptionally active. Up-regulation of SF2/ASF and
nRNP A1 could facilitate in a general manner efficient andre important in the early stages of splicing (Reed, 2000).
The data presented here demonstrate that hnRNP A1 may
nteract directly and specifically with the HPV16 LRE. In dif-
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Table 2
Sequence of binding sites for hnRNP A1
Binding site Sequence Reference
hnRNP A1 consensus
Selex high affinity
binding site
UAGGGU Burd and
Dreyfuss (1994)
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C1 ORF binding sites CAGGG/AU Zhao et al. (2004)
utative LRE binding site UUAGUGU This manuscript
erentiated W12 cell extracts at least one major LRE/protein
omplex is formed that contains hnRNP A1. This complex is in
he nucleus and so is likely involved in nuclear RNA process-
ng. Analysis of the LRE sequence revealed one good candidate
nRNP A1 binding site (UUAGUGU) (Burd and Dreyfuss,
994), located in the middle of the LRE (Fig. 1, Table 2). How-
ver, use of deletion mutations of the LRE in UV crosslinking
evealed that no simple mutation abrogated hnRNP A1 binding
uggesting that several motifs within the sequence cooperate
o allow interaction with hnRNP A1 (data not shown). EMSA
emonstrated that binding to the U-rich 3′ LRE was weak but
inding to the 5′ region containing four 5′ splice sites and the
utative hnRNP A1 binding site was stronger, but not as strong as
inding to the entire LRE. GST-hnRNP A1 binding experiments
ndicated that the LRE bound hnRNP A1 with medium affinity
ccording to Selex analysis of hnRNP A1 high affinity binding
ites (Burd and Dreyfuss, 1994). Interestingly, in Selex the win-
ing sequence was very similar to consensus vertebrate 5′ and
′ splice sites. Thus, it is possible that the four weak 5′ splice
ites in the LRE together with the putative hnRNP A1 binding
ite could help recruit hnRNP A1. In addition, it is known that
nRNP proteins bind U-rich sequences promiscuously so some
inding to the 3′ LRE is expected. Whether hnRNP A1 binds
he LRE as part of the splicing-like complex that the element
lso binds (Cumming et al., 2003), or indeed competes with this
omplex for binding to the LRE, remains to be tested.
hnRNP A1 has been demonstrated to bind a cis-acting RNA
equence in the HPV16 L1 coding region in HeLa cells trans-
ected with an expression construct for the entire HPV16 coding
egion (Zhao et al., 2004). This binding suppressed the use of
he 3′ splice site located immediately upstream of the L1 AUG,
esulting in inhibition of splicing from the major 5′ splice site
n the early region to the L1 3′ splice site. Thus, splicing of
ny L1 transcripts synthesised in undifferentiated virus-infected
ells would be inhibited. This fits with our observation of the
resence of unprocessed, nonpolyadenylated late transcripts in
ndifferentiated W12 cells (Milligan et al., 2007). It is possible
hat the HPV16 LRE could cooperate with the L1 coding region
inding site to inhibit HPV16 late gene expression. However, in
he experiments in HeLa cells the LRE had to be deleted from
he HPV16 genome to achieve efficient late gene expression.
his implies that the LRE may have a more important role than
he L1 coding region regulatory sequence in repressing late gene
xpression in undifferentiated epithelial cells. Further, since we
ave shown that levels of hnRNP A1 are low in undifferentiated
12 cells it is currently unclear whether hnRNP A1 suppression
f late region splicing occurs in a real infection.
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. Conclusions
We have demonstrated an increase in hnRNP A1 levels in
PV16 infected, differentiated epithelial cells, which parallels
hat seen for SF2/ASF (McPhillips et al., 2004). Binding of
nRNP A1 to the LRE in the late 3′ UTR may regulate RNA
rocessing. However, hnRNP A1 can have positive as well as
egative effects on gene expression (Blanchette and Chabot,
999) and can act on cellular processes, both nuclear and cyto-
lasmic other than splicing regulation (Krecic and Swanson,
999). A combination of different regulatory events is likely in
egulation of HPV16 late gene expression.
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